|
18 Apr 2025 |
UltraTech Cement
|
Consensus Share Price Target
|
11901.00 |
12501.08 |
- |
5.04 |
buy
|
|
|
|
|
28 Mar 2025
|
UltraTech Cement
|
Sharekhan
|
11901.00
|
13000.00
|
11509.55
(3.40%)
|
9.23 |
Buy
|
|
|
The cement sector is increasingly consolidating, enabling companies to expand geographically, secure vital limestone reserves, and achieve economies of scale. Acquisitions are allowing market leaders to scale up quickly and strengthen their competitive positions.
|
|
03 Mar 2025
|
UltraTech Cement
|
Axis Direct
|
11901.00
|
13510.00
|
10340.80
(15.09%)
|
13.52 |
Buy
|
|
|
We maintain our BUY rating on the stock.
|
|
03 Mar 2025
|
UltraTech Cement
|
Sharekhan
|
11901.00
|
13000.00
|
10340.80
(15.09%)
|
9.23 |
Buy
|
|
|
UltraTech Cement’s capacity expansion remains a cornerstone of its growth strategy. By FY25, its cement capacity is projected to reach 182.8 million tonnes (28% of India’s total cement capacity) with plans to scale it to 209 million tonnes by FY27, through both organic and inorganic growth.
|
|
01 Mar 2025
|
UltraTech Cement
|
BOB Capital Markets Ltd.
|
11901.00
|
13137.00
|
10128.45
(17.50%)
|
10.39 |
Buy
|
|
|
UTCEM allocates Rs18bn (~2% of capital allocation) in the building material value chain by investing in wire and cable business
|
|
03 Feb 2025
|
UltraTech Cement
|
Axis Direct
|
11901.00
|
12385.00
|
11174.65
(6.50%)
|
4.07 |
Buy
|
|
|
We recommend a BUY on the stock for a target price of Rs 12,385 implying an upside of 10% from CMP
|
|
31 Jan 2025
|
UltraTech Cement
|
Geojit BNP Paribas
|
11901.00
|
12650.00
|
11487.45
(3.60%)
|
6.29 |
Buy
|
|
|
|
|
24 Jan 2025
|
UltraTech Cement
|
Sharekhan
|
11901.00
|
13000.00
|
11285.85
(5.45%)
|
9.23 |
Buy
|
|
|
UltraTech Cement (UltraTech) reported broadly in-line standalone revenue at Rs. 16,328 crore (up 1.2% y-o-y) for Q3FY2025, led by strong volume growth of 10.6% y-o-y, while blended realizations were lower 8.5% y-o-y. Blended standalone EBITDA/tonne stood at Rs. 965, down 20.2% y-o-y while a good improvement of 31.9% q-o-q.
|
|
24 Jan 2025
|
UltraTech Cement
|
BOB Capital Markets Ltd.
|
11901.00
|
13137.00
|
11285.85
(5.45%)
|
10.39 |
Buy
|
|
|
Healthy 10% YoY volume growth aids flat topline despite 9% dent in realisations in a challenging Q3; capacity utilisation at ~76%
|
|
24 Jan 2025
|
UltraTech Cement
|
IDBI Capital
|
11901.00
|
13233.00
|
11285.85
(5.45%)
|
11.19 |
Buy
|
|
|
|
|
24 Jan 2025
|
UltraTech Cement
|
Axis Direct
|
11901.00
|
13510.00
|
11285.85
(5.45%)
|
13.52 |
Buy
|
|
|
We maintain our BUY recommendation on the stock.
|
|
24 Jan 2025
|
UltraTech Cement
|
KRChoksey
|
11901.00
|
12699.00
|
11285.85
(5.45%)
|
6.71 |
Accumulate
|
|
|
• UltraTech Cement’s earnings for Q3FY25 exceeded our expectations, while revenue aligned with our forecasts. • Revenue for Q3FY25 came in at INR 171,933 Mn, up 2.7% YoY (+10.0% QoQ). The QoQ growth was driven by higher realization and robust volume expansion.
|
|
23 Jan 2025
|
UltraTech Cement
|
Motilal Oswal
|
11901.00
|
13800.00
|
11420.90
(4.20%)
|
15.96 |
Buy
|
|
|
UltraTech Cement’s (UTCEM) 3QFY25 operating performance was in line with our estimate, with EBITDA standing at INR28.9b (declined 11% YoY). EBITDA/t stood at INR951 (-20% YoY; vs. est. INR925).
|
|
06 Nov 2024
|
UltraTech Cement
|
Geojit BNP Paribas
|
11901.00
|
12320.00
|
11274.40
(5.56%)
|
3.52 |
Buy
|
|
|
|
|
22 Oct 2024
|
UltraTech Cement
|
ICICI Securities Limited
|
11901.00
|
10555.00
|
10869.30
(9.49%)
|
Target met |
Hold
|
|
|
UltraTech Cement’s (UTCEM) focus on increasing its capacity/market share and enhancing efficiency remains heartening. However, in Q2FY25, the sectoral pangs of subdued demand and weak prices got the better of the industry leader.
|
|
22 Oct 2024
|
UltraTech Cement
|
Axis Direct
|
11901.00
|
12000.00
|
10825.15
(9.94%)
|
Target met |
Buy
|
|
|
We maintain our BUY rating on the stock with a TP of Rs 12,000/share, implying an upside potential of 10% from the CMP.
|
|
22 Oct 2024
|
UltraTech Cement
|
ICICI Direct
|
11901.00
|
13500.00
|
10825.15
(9.94%)
|
13.44 |
Buy
|
|
|
|
|
22 Oct 2024
|
UltraTech Cement
|
Prabhudas Lilladhar
|
11901.00
|
12401.00
|
10825.15
(9.94%)
|
4.20 |
Accumulate
|
|
|
|
|
22 Oct 2024
|
UltraTech Cement
|
KRChoksey
|
11901.00
|
12063.00
|
10825.15
(9.94%)
|
Target met |
Accumulate
|
|
|
UltraTech Cement’s earnings for Q2FY25 exceeded our expectations, while revenue aligned with our forecasts. Revenue for Q2FY25 came in at INR 156,347 Mn, down 2.4% YoY (-13.5% QoQ) was largely in line with our estimates.
|
|
22 Oct 2024
|
UltraTech Cement
|
BOB Capital Markets Ltd.
|
11901.00
|
12469.00
|
10825.15
(9.94%)
|
4.77 |
Buy
|
|
|
Steady 3% volume growth aids marginal fall in topline despite dent in realisations in a challenging Q2; capacity utilisation at ~68%
|
|
21 Oct 2024
|
UltraTech Cement
|
Motilal Oswal
|
11901.00
|
13000.00
|
10869.30
(9.49%)
|
9.23 |
Buy
|
|
|
UltraTech Cement (UTCEM)’s 2QFY25 EBITDA was below our estimate due to higher-than-estimated opex/t. EBITDA declined ~21% YoY to INR20.2b (7% miss).
|